Active — Not RecruitingNot Applicable

the Value of Flexible Bronchoscopy in the Neonatal Intensive Care Unit at Sohag University Hospitals

Egypt100 participantsStarted 2025-09-10

Plain-language summary

The aim of this study to describe the utility of flexible fiberoptic bronchoscopy for the diagnosis and management of different respiratory diseases in the neonatal ICU.

Who can participate

Age range

1 Day – 28 Days

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * neonates aged from 1 day to 28 days with recurrent dyspnea, stridor, recurrent chocking or suspicious respiratory tract anomaly; with recurrent pulmonary infection or atelectasis in the same lung lobe; with suspicious tracheal stenosis in radiological image \[X-ray or computed tomography (CT) scan\]; inability to be extubated without clear reason; or confirmed congenital esophageal atresia to clarify the presence and position of esophagobronchial fistula before surgery. Exclusion Criteria: neonates with neurological , cardiac problem ,age above 28 days \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

the number of patients underwent flexible bronchoscopy in NICU at sohag university hospitals

Timeframe: immediatly after bronchoscopy

diagnosis of each neonate which reached by the broncscopy

Timeframe: immediatly after bronchoscopy

Trial details

NCT IDNCT07211971

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-10

View on ClinicalTrials.gov More Study Including Neonates Who Underwent Flexible Fiberoptic Bronchoscopy in Last 10 Years at Sohag University Hospitals trials

Who can participate

Age range

1 Day – 28 Days

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.